Open AccessRITUXIMAB INDUCTION IN HIGH RISK KIDNEY TRANSPLANT RECIPIENTS MAY DECREASE THE INCIDENCE AND SEVERITY OF RECURRENCE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS.
Author(s) -
Junichiro Sageshima,
Gaetano Ciancio,
Alessia Fori,
L Chen,
Carolyn Abitbol,
Jayanthi Chandar,
Warren Kupin,
David Roth,
Gastón Zilleruelo,
George W. Burke
Publication year - 2008
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000332017.62163.9e
Subject(s) - medicine , rituximab , focal segmental glomerulosclerosis , incidence (geometry) , urology , kidney transplantation , gastroenterology , kidney , glomerulonephritis , lymphoma , physics , optics